Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
CervoMed a clinical-stage firm focused on discovering therapies for brain degenerative illnesses.
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.
NAPIGEN is a biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes, and animals.
MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Forward Therapeutics is a biopharma comapny targeting treatment of chronic inflammatory disorders.
Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.
Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.
Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.
Ventricle Health offers evidence-based therapy, remote patient monitoring, patient education, and advocacy services for cardiac care.
Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins.
Mariana Oncology is a biotechnology research industry.
RNA based vaccines with tolerability close to the standard of care by dampening an excessive innate immune response
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
Ocelot Bio brings new treatment options to patients with severe liver disease.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.
RA Capital Management has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 20 different industry categories.
Among tracked funding rounds, Cerevel Therapeutics received $450.0M in a Post Ipo Equity round. RA Capital Management's total known invested capital is $56.7B.
RA Capital Management's average investment size is $123.5M across its portfolio of 467 companies.
Recent RA Capital Management portfolio additions include CervoMed, Stoke Therapeutics, Capstan Therapeutics, Napigen, MMI. These companies were founded in 2020 or later.